Ani Pharmaceuticals (ANIP) Gross Profit Growth (1y) (2013 - 2026)
Ani Pharmaceuticals (ANIP) Gross Profit Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 5.06% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 2.59% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -18.38% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -7.66% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -0.34% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 42.12% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 14.77% |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.33 Bn | 143.88 Mn | 15.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.95% |
| Dec 31, 2025 | 33.09% |
| Sep 30, 2025 | 57.67% |
| Jun 30, 2025 | 70.22% |
| Mar 31, 2025 | 40.57% |
| Dec 31, 2024 | 40.98% |
| Sep 30, 2024 | 1.83% |
| Jun 30, 2024 | 8.19% |
| Mar 31, 2024 | 27.79% |
| Dec 31, 2023 | 35.11% |
| Sep 30, 2023 | 64.41% |
| Jun 30, 2023 | 92.59% |
| Mar 31, 2023 | 128.69% |
| Dec 31, 2022 | 114.22% |
| Sep 30, 2022 | 84.20% |
| Jun 30, 2022 | 46.56% |
| Mar 31, 2022 | 443.84% |
| Dec 31, 2021 | -17.37% |
| Sep 30, 2021 | -15.86% |
| Jun 30, 2021 | -5.27% |